NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 78 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2015. The put-call ratio across all filers is 97.39 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $17,000 | -32.0% | 27,075 | 0.0% | 0.00% | – |
| Q3 2016 | $25,000 | +78.6% | 27,075 | 0.0% | 0.00% | – |
| Q2 2016 | $14,000 | -97.3% | 27,075 | -95.1% | 0.00% | -100.0% |
| Q1 2016 | $521,000 | -28.1% | 551,786 | +1.3% | 0.00% | 0.0% |
| Q4 2015 | $725,000 | -41.4% | 544,748 | +0.4% | 0.00% | -50.0% |
| Q3 2015 | $1,237,000 | +36.8% | 542,478 | -3.4% | 0.00% | +100.0% |
| Q2 2015 | $904,000 | +24.5% | 561,782 | +23.1% | 0.00% | 0.0% |
| Q1 2015 | $726,000 | -15.6% | 456,457 | +0.4% | 0.00% | 0.0% |
| Q4 2014 | $860,000 | +42.6% | 454,830 | -0.4% | 0.00% | 0.0% |
| Q3 2014 | $603,000 | -8.2% | 456,831 | +2.9% | 0.00% | 0.0% |
| Q2 2014 | $657,000 | +1.9% | 444,162 | +27.4% | 0.00% | 0.0% |
| Q1 2014 | $645,000 | -10.2% | 348,556 | +0.5% | 0.00% | 0.0% |
| Q4 2013 | $718,000 | -22.8% | 346,652 | -1.2% | 0.00% | -50.0% |
| Q3 2013 | $930,000 | +5.9% | 350,929 | +6.7% | 0.00% | 0.0% |
| Q2 2013 | $878,000 | – | 328,817 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |